1 |
Y. Malam, M. Loizidou, A. M. Seifalian, "Liposome and nanoparticles: nanosized vehicles for drug delivery in cancer," Trends in Pharmacological Science, vol. 30, no.11 pp. 592-599, Nov. 2009.
DOI
|
2 |
L. H. Reddy, "Drug delivery to tumours: recent strategies," Journal of Pharmacy and Pharmacology, vol. 57, no. 10, pp. 1231- 1242, Oct. 2005.
DOI
|
3 |
V. Lorusso, L. Manzione, N. Silvestris, "Role of liposomal anthracyclines in breast cancer," Annals of Oncology, vol. 18, no. 6, vi70-vi73, Jun. 2007.
|
4 |
R. I. Pakunlu, Y. Wang, M. Saad, J. J. Khandare, V. Starovoytov, T. Minko, "In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug," Journal of Controlled Release, vol. 114, no. 2, pp. 153-162, Aug. 2006.
DOI
|
5 |
Y. Godfrin, F. Horand, R. Franco, E. Dufour, E. Kosenko, B. Bax, A Banz, O. Skorokhod, J. Lanao, V. Vitvitsky, E. Sinauridze, V. Bourgeaux, K. C. Gunter, "International Seminar on the Red Blood Cells as Vehicles for Drugs," Expert Opinion on Biological Therapy, vol. 12, no. 1, pp. 127-133, Jan. 2012.
DOI
|
6 |
S. W. Choe, D. S. Terman, A. E. Rivers, J. Rivera, R. Lottenberg, B. S. Sorg, "Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery," Journal of Controlled Release, vol. 171, no. 2, pp. 184-192, Oct. 2013.
DOI
|